ISSAR Pharma

Therapeutic Areas

Over 25 years of Peptide Drug Research and Discovery

Our Brands

Over 2,000,000 scientist hours into new peptide drug development, ISSAR has touched 100000 plus lives

Development Pipeline

Solving the unmet healthcare needs using novel peptide technology

Novoskin®
Vitiligo - Topical

Xylentra®
Wound care - Topical

IS -107
Solid tumors - Injectable

IS - 217
Soriacare®
Psoriasis - Injectable
Topical

ISSAR'S Pre-Clinical
Pipeline

INDIA
INDIA
US FDA
INDIA
US FDA
IBD (Injectable)
Sepsis (Injectable)
Rheumatoid Arthritis
Atopic Dermatitis